Courses | Page 4 | NCCN Continuing Education

Title	Credits	Start date - Expiration date
Adjuvant and Neoadjuvant Therapies for Early Stage Breast Cancer, Including SABCS Updates	1.00	03/15/2020 - 12:00am to 03/15/2021 - 12:00am
Surgical Management of Breast Cancer, Including SABCS Updates	0.56	03/15/2020 - 12:00am to 03/15/2021 - 12:00am
Is There a Role for Proton Therapy in the Treatment of Breast Cancer?	0.50	03/15/2020 - 12:00am to 03/15/2021 - 12:00am
Principles of Breast Reconstruction after Surgery	0.50	03/15/2020 - 12:00am to 03/15/2021 - 12:00am
Management of Rare Breast Cancers	0.50	03/15/2020 - 12:00am to 03/15/2021 - 12:00am
Biomarker Assays for Treatment Selection of Advanced Breast Cancer	0.53	03/15/2020 - 12:00am to 03/15/2021 - 12:00am
Management of Metastatic Breast Cancer, Including SABCS Updates	0.75	03/15/2020 - 12:00am to 03/15/2021 - 12:00am
Management of Toxicities with Targeted Therapies for Breast Cancer	0.36	03/15/2020 - 12:00am to 03/15/2021 - 12:00am
Practical Application of Immuno-Oncology in Renal Cell Carcinoma	1.75	03/17/2020 - 12:00am to 03/17/2021 - 12:00am
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Lung Cancer	1.00	03/18/2020 - 12:00am to 03/18/2021 - 12:00am
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Multiple Myeloma	0.75	03/18/2020 - 12:00am to 03/18/2021 - 12:00am
BCOP Test - Current Therapy Options for Graft-Versus-Host Disease		04/01/2020 - 2:00pm to 04/01/2021 - 12:00am
Recorded Presentation from the NCCN Pharmacy Updates: Current Therapy Options for Graft-Versus-Host Disease	1.00	04/07/2020 - 12:00am to 04/01/2021 - 12:00am
NCCN Guidelines® Insights - Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020	1.00	04/10/2020 - 12:00am to 04/10/2021 - 12:00am
Talking to Patients about Cancer Treatment, Risk Factors, and Treatment Cessation during the COVID-19 Pandemic	1.00	04/20/2020 - 12:00am to 04/20/2021 - 12:00am

Pages